Privia Health Group, Inc. reported first quarter ended March 31, 2026 results: revenue $ 603.8, net income $ 3.1, EPS $ 0.02. Guidance reaffirmed.
“results for the first quarter ended March 31, 2026. Three Months Ended March 31, (unaudited; $ in millions, except per share amounts) 2026 2025 Change (%) * Total revenue $ 603.8 $ 480.1 25.8 % Gross profit $ 125.6 $ 103.6 21.2 % Operating income $ 7.4 $ 5.2 42.2 % Net income a $ 3.1 $ 4.2 (27.4) % Non-GAAP adjusted net income b $ 24.3 $ 19.9 22.3 % Net”
Bill Sullivan resigned as Director at Privia Health Group, Inc..
“On July 1, 2024, Bill Sullivan resigned from his position as a member of the Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) and as a member of the Audit Committee of the Board, effective immediately.”
Earnings Releases
Privia Health Group, Inc. reported the first quarter ended March 31, 2024 results: revenue $ 415.2, net income $ 3.0, EPS $ 0.03. Guidance reaffirmed.
“Privia Health Reports First Quarter 2024 Financial Results – Practice Collections +7.4% compared to 1Q’23 – Implemented Providers +17.3% compared to 1Q’23 – Company Reiterated Full Year 2024 Guidance ARLINGTON, VA – May 9, 2024 – Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2024. For the Three Months Ended March 31, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue $ 415.2 $ 386.3 7.5 % Gross profit $ 93.4 $ 83.0 12.5 % Operating income $ 0.8 $ 6.7 (87.7) % Net income a $ 3.0 $ 7.3 (59.3) % Non-GAAP adjusted net income b $ 22.5 $ 19.3 16.6 % Net income per share $ 0.03 $ 0.06 (50.0) % Non-GAAP adjusted net income per share $ 0.18 $ 0.16 12.5 %”
Earnings Releases
Privia Health Group, Inc. reported financial results for the fourth quarter and full year ended December 31, 2023.
“On February 27, 2024, Privia Health Group, Inc. (the “Company”) issued a press release announcing its financial results for the fourth quarter ended December 31, 2023.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.